289P Risk factors for interstitial lung disease in patients treated with trastuzumab deruxtecan from two interventional studies
Charles A. Powell, D. Ross Camidge, Shanu Modi, A. Qin, Corina Taitt, C. Lee, Michelle D. Hackshaw, Jasmeet Singh, Hiroji Iwata
Topics & Concepts
MedicineInternal medicineIncidence (geometry)Interstitial lung diseaseTrastuzumabLogistic regressionPopulationGastroenterologyOncologySurgeryCancerLungBreast cancerEnvironmental healthOpticsPhysicsHER2/EGFR in Cancer ResearchLung Cancer Treatments and MutationsGastric Cancer Management and Outcomes